Home > Cashflow Statement > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Cashflow Statement

COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Cashflow Statement History

[Consolidated]

Mar2024Mar2023Mar2022Mar2017Mar2016
Profit Before Tax₹34 Cr₹27 Cr₹26 Cr₹16 Cr₹16 Cr
Adjustment ₹-3.48 Cr₹-6.11 Cr₹-7.16 Cr₹0.71 Cr₹1.14 Cr
Changes In working Capital ₹-28 Cr₹-3.26 Cr₹3.58 Cr₹1.29 Cr₹12 Cr
Cash Flow after changes in Working Capital ₹2.13 Cr₹17 Cr₹23 Cr₹18 Cr₹30 Cr
Cash Flow from Operating Activities ₹-5.96 Cr₹11 Cr₹16 Cr₹14 Cr₹24 Cr
Cash Flow from Investing Activities ₹83 Cr₹-45 Cr₹-27 Cr₹-18 Cr₹-23 Cr
Cash Flow from Financing Activities ₹-15 Cr₹35 Cr₹8.29 Cr₹4.67 Cr₹-2.41 Cr
Net Cash Inflow / Outflow ₹63 Cr₹0.58 Cr₹-2.45 Cr₹0.83 Cr₹-1.08 Cr
Opening Cash & Cash Equivalents ₹0.88 Cr₹0.30 Cr₹2.75 Cr₹5.69 Cr₹6.77 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹63 Cr₹0.88 Cr₹0.30 Cr₹6.52 Cr₹5.69 Cr

Compare Cashflow Statement of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,690.1 Cr 4.5% 1.6% -30.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹387,792.0 Cr 2.3% -0.4% -12.4% Stock Analytics
DIVIS LABORATORIES ₹159,986.0 Cr 0% 1.1% 10.7% Stock Analytics
CIPLA ₹127,126.0 Cr 2.1% 3.5% -4.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,700.0 Cr -1.2% -1.7% 4.5% Stock Analytics
DR REDDYS LABORATORIES ₹109,868.0 Cr 5.3% 7.9% -2% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

4.5%

1.6%

-30.3%

SENSEX

1.5%

1.6%

0.4%


You may also like the below Video Courses